Browsing Interface : Welcome guest : log in
Home |  Graph |  LogLearn |  Editor |  ]  KB:  Language: 
  Formal Language: 



KB Term:  Term intersection
English Word: 

  MysteryStory

Sigma KEE - USNonPrescriptionDrug
USNonPrescriptionDrug(OTC drug)

appearance as argument number 1
-------------------------


(instance USNonPrescriptionDrug NormativeAttribute) Mid-level-ontology.kif 10815-10815 OTC drug is an instance of normative attribute
(documentation USNonPrescriptionDrug EnglishLanguage "A Medicine that in the UnitedStates may be sold to a patient with a doctor's prescription.") Mid-level-ontology.kif 10816-10818 OTC drug is an instance of normative attribute

appearance as argument number 2
-------------------------


(termFormat EnglishLanguage USNonPrescriptionDrug "non-prescription drug") Mid-level-ontology.kif 10819-10819
(termFormat EnglishLanguage USNonPrescriptionDrug "over the counter drug") Mid-level-ontology.kif 10820-10820
(termFormat EnglishLanguage USNonPrescriptionDrug "OTC drug") Mid-level-ontology.kif 10821-10821

antecedent
-------------------------


(=>
    (attribute ?X USNonPrescriptionDrug)
    (modalAttribute
        (exists (?B)
            (and
                (instance ?B Buying)
                (objectTransferred ?B ?X)
                (not
                    (exists (?P)
                        (and
                            (instance ?P Prescription)
                            (refers ?P ?X)))))) Legal))
Mid-level-ontology.kif 10823-10835 If OTC drug is an attribute of X, then the statement there exists Y such that Y is an instance of buying, the object transferred in Y is X, there doesn't exist Z such that Z is an instance of prescription, and Z includes a reference to X has the modal force of legal


Show simplified definition (without tree view)
Show simplified definition (with tree view)

Show without tree


Sigma web home      Suggested Upper Merged Ontology (SUMO) web home
Sigma version 3.0.0-0a80e6c8 (2026-05-12) is open source software produced by Articulate Software and its partners